中国生物科技服务(08037)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08037 中国生物科技服务

休市中 12-05 15:56:59

0.930

+0.030

+3.33%

最高0.940	最低0.890	成交量8.00万
今开0.940	昨收0.900	日振幅5.56%
总市值9.07亿	流通市值9.07亿	总股本9.76亿
成交额7.29万	换手率0.01%	流通股本9.76亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08037","market":"HK","secType":"STK","nameCN":"中国生物科技服务","latestPrice":0.93,"timestamp":1764921419268,"preClose":0.9,"halted":0,"volume":80000,"delay":0,"floatShares":975731150,"shares":975731150,"eps":-0.204592,"marketStatus":"休市中","change":0.03,"latestTime":"12-05 15:56:59","open":0.94,"high":0.94,"low":0.89,"amount":72900,"amplitude":0.055556,"askPrice":0.93,"askSize":15000,"bidPrice":0.89,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":-0.154128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1087401600000,"exchange":"SEHK","adjPreClose":0.9,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.8333333330729167,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08037","defaultTab":"news","newsList":[{"id":"2586428479","title":"中国生物科技服务(08037)：硼中子治疗装置成功实现首次出束","url":"https://stock-news.laohu8.com/highlight/detail?id=2586428479","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586428479?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:20","pubTimestamp":1764080412,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物科技服务 发布公告，集团位于中国海南博鳌乐城国际医疗旅游先行区之旗舰项目 — 鹏博(海南)硼中子医院于2025年11月20日取得重大进展。凭借海南博鳌乐城国际医疗旅游先行区的支持政策优势，该系统为全球目前唯一获得正式医疗器械注册证、并可直接应用于常规临床治疗的硼中子治疗系统，相关临床治疗服务预计于2026年第一季度正式开展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1511","BK1219","08037"],"gpt_icon":0},{"id":"2579812712","title":"中国生物科技服务10月30日主力净流出21.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2579812712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579812712?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:15","pubTimestamp":1761812143,"startTime":"0","endTime":"0","summary":"10月30日, 中国生物科技服务股价跌6.98%，报收0.80元，成交金额92.6万元，换手率0.12%，振幅11.63%，量比1.13。中国生物科技服务今日主力资金净流出21.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌13.04%，主力资金累计净流出21.6万元；近20日主力资金累计净流出224.8万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103016193394e522f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103016193394e522f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1511","BK1219","08037"],"gpt_icon":0},{"id":"2574105032","title":"中国生物科技服务10月10日主力净流出82.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2574105032","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574105032?lang=zh_cn&edition=full","pubTime":"2025-10-10 16:16","pubTimestamp":1760084165,"startTime":"0","endTime":"0","summary":"10月10日, 中国生物科技服务股价跌1.00%，报收0.99元，成交金额115.1万元，换手率0.12%，振幅3.00%，量比3.08。中国生物科技服务今日主力资金净流出82.5万元，上一交易日主力净流出0万元。该股近5个交易日下跌1.00%，主力资金累计净流出82.5万元；近20日主力资金累计净流出168.0万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101016235494c19d60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101016235494c19d60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1219","08037","BK1511"],"gpt_icon":0},{"id":"2569793184","title":"中国生物科技服务09月23日主力净流出20.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2569793184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569793184?lang=zh_cn&edition=full","pubTime":"2025-09-23 16:15","pubTimestamp":1758615345,"startTime":"0","endTime":"0","summary":"09月23日，中国生物科技服务股价收平报1.04元，成交金额171.6万元，换手率0.17%，振幅4.81%，量比1.10。中国生物科技服务今日主力资金净流出20.2万元，上一交易日主力净流出0万元。该股近5个交易日下跌4.59%，主力资金累计净流出85.5万元；近20日主力资金累计净流出85.5万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923163427a43e4453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923163427a43e4453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08037","BK1511","BK1219"],"gpt_icon":0},{"id":"2566393953","title":"中国生物科技服务(08037)附属获授本金最高为1.8亿元的贷款","url":"https://stock-news.laohu8.com/highlight/detail?id=2566393953","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566393953?lang=zh_cn&edition=full","pubTime":"2025-09-11 12:28","pubTimestamp":1757564898,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物科技服务 发布公告，于2025年9月9日，鹏博(海南)硼中子医疗科技有限公司与海南农村商业银行股份有限公司琼海支行订立一份贷款合同。据此，贷款人同意向鹏博(海南)提供本金最高为人民币1.8亿元的贷款。该贷款将为硼中子俘获治疗中心的建设提供更多助力，争取该中心在2025年年底开幕及开始营运，为有需要癌症患者提供硼中子治疗服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1344003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","08037","BK1511"],"gpt_icon":0},{"id":"1122842673","title":"异动解读 | 中国生物科技服务盘中大跌5.88%，尽管中期亏损收窄近六成","url":"https://stock-news.laohu8.com/highlight/detail?id=1122842673","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122842673?lang=zh_cn&edition=full","pubTime":"2025-08-28 09:38","pubTimestamp":1756345126,"startTime":"0","endTime":"0","summary":"中国生物科技服务今日盘中大跌5.88%，引发市场关注。这一跌幅出现在公司发布2025年中期业绩后，尽管财报显示公司亏损状况有所改善。根据公司公告，中国生物科技服务2025年上半年收入达3887.2万港元，同比增长19.79%。公司拥有人应占亏损收窄至3200.6万港元，同比大幅收窄59.95%。分析人士指出，虽然亏损收窄，但公司仍未能实现盈利，这可能引发了市场对其长期发展前景的担忧。市场将继续关注公司未来的业务发展战略及其执行情况。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["08037"],"gpt_icon":0},{"id":"2562172813","title":"中国生物科技服务(08037)公布中期业绩 公司拥有人应占亏损3200.6万港元 同比收窄59.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562172813","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562172813?lang=zh_cn&edition=full","pubTime":"2025-08-27 23:10","pubTimestamp":1756307420,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物科技服务(08037)公布2025年中期业绩，收入3887.2万港元，同比增长19.79%;公司拥有人应占亏损3200.6万港元，同比收窄59.95%;每股亏损0.033港元。公告称，亏损改善的主要原因是公司成功实施成本控制措施，导致毛利率上升及行政开支减少，以及就2024年发生的暴雨对海南建筑工地造成的损害作出保险申索而获得赔偿收入约1370万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1336774.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","08037","BK1511"],"gpt_icon":0},{"id":"2558228685","title":"中国生物科技服务预计中期亏损不超3300万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558228685","media":"瑞财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558228685?lang=zh_cn&edition=full","pubTime":"2025-08-10 16:24","pubTimestamp":1754814260,"startTime":"0","endTime":"0","summary":"财中社8月8日电中国生物科技服务（08037）发布公告，预计截至2025年6月30日的中期期间，公司拥有者应占亏损将不超过3300万港元，较2024年同期的7992万港元减少约59%。此次亏损减少的主要原因是公司成功实施了成本控制措施，导致毛利率上升及行政开支减少。此外，公司还获得了约1400万港元的保险赔偿收入，涉及2024年暴雨对海南建筑工地造成的损害。公告指出，上述数据基于管理层对管理账目的初步审阅和评估，尚未经过公司核数师或审核委员会的审阅，可能会进行调整。公司预计将在2025年8月底发布未经过审计的中期业绩。股东及潜在投资者在买卖公司股份时需谨慎行事。来源：财中社","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081016242394dab49f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081016242394dab49f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1511","08037","BK1219"],"gpt_icon":0},{"id":"2557948524","title":"中国生物科技服务(08037)预计中期股东应占亏损同比减少约59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557948524","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557948524?lang=zh_cn&edition=full","pubTime":"2025-08-08 20:24","pubTimestamp":1754655840,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物科技服务(08037)发布公告，预计2025年中期期间公司拥有人应占亏损将不多于3300万港元，较2024年同期公司拥有人应占亏损7991.7万港元减少约59%。该显著经营表现改善的主要原因是公司成功实施成本控制措施，导致毛利率上升及行政开支减少，以及就2024年发生的暴雨对海南建筑工地造成的损害作出保险申索而获得赔偿收入约1400万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","BK1511","08037"],"gpt_icon":0},{"id":"2554793473","title":"中国生物科技服务(08037)委任尹烨为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2554793473","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554793473?lang=zh_cn&edition=full","pubTime":"2025-07-25 22:31","pubTimestamp":1753453919,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物科技服务(08037)公布，尹烨博士已获委任为执行董事，张晓博士已获委任为独立非执行董事及审核委员会成员，自2025年7月25日起生效。同日起，钱红骥先生因需要投放更多精力处理其他业务，已辞任独立非执行董事及审核委员会成员。此外，为投放更多时间处理其他事务，林德明先生已辞任该公司公司秘书及公司授权代表，公司财务总监冯佩贤女士已获委任为公司秘书及授权代表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08037","BK1219","BK1511"],"gpt_icon":0},{"id":"2551941987","title":"中国生物科技服务(08037)：华大松禾以借款转股方式认购 Dynamic Healthcare 持股最多 6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551941987","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551941987?lang=zh_cn&edition=full","pubTime":"2025-07-13 19:24","pubTimestamp":1752405847,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物科技服务 发布公告，有关该投资的正式协议于2025年7月11日订立。在实际上，借款将转换为Dynamic Healthcare的股份。假设A轮融资不涉及对Dynamic Healthcare的其他股份认购，华大松禾将持有经发行认股权证股份及将向嘉博众治(海南)发行的股份扩大后的Dynamic Healthcare已发行股本最多6.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1511","BK1219","08037"],"gpt_icon":0},{"id":"2550194671","title":"中国生物科技服务(08037)订立有关硼中子治疗医疗保险产品合作的谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=2550194671","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550194671?lang=zh_cn&edition=full","pubTime":"2025-07-11 06:23","pubTimestamp":1752186210,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物科技服务 发布公告，于2025年7月10日，公司、安盛保险(百慕达)有限公司，于百慕达注册成立的有限公司，及安盛环球再保险(上海)有限公司、前海再保险股份有限公司及Arthur J. Gallagher  Pte. Ltd.订立一份不具法律约束力的谅解备忘录，内容有关共同开发覆盖硼中子治疗治疗费用及相关服务的普惠型医疗保险产品的合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1316508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08037","BK1511","BK1219"],"gpt_icon":0},{"id":"2545285529","title":"中证港股通制药与生物科技服务综合指数报824.54点，前十大权重包含晶泰控股等","url":"https://stock-news.laohu8.com/highlight/detail?id=2545285529","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545285529?lang=zh_cn&edition=full","pubTime":"2025-06-24 18:09","pubTimestamp":1750759771,"startTime":"0","endTime":"0","summary":"数据统计显示，中证港股通制药与生物科技服务综合指数近一个月上涨7.89%，近三个月下跌1.89%，年至今上涨34.60%。从中证港股通制药与生物科技服务综合指数持仓的市场板块来看，香港证券交易所占比100.00%。遇临时调整时，当中证港股通综合指数调整样本时，样本随之进行相应调整。若中证港股通综合指数样本有特殊事件发生，导致其行业归属发生变化，指数样本进行相应调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624181414978caeff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624181414978caeff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02228","01477","BK1141","08037","BK1617","BK1219","07226","BK1511","BK1191","HSTECH"],"gpt_icon":1},{"id":"2516680501","title":"中国生物科技服务预计2024财年亏损约1.8亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516680501","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516680501?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:05","pubTimestamp":1741003512,"startTime":"0","endTime":"0","summary":"3月3日，中国生物科技服务（08037）发布公告，预计在2024财年将录得公司拥有者应占亏损净额约1.8亿港元，相比2023财年的亏损净额约9545万港元，亏损大幅增加约8455万港元。董事会指出，亏损增加的主要原因包括COVID-19核酸检测需求减少，市场竞争加剧，导致收入下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503033334998983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["08037","BK1219","BK1511"],"gpt_icon":0},{"id":"2514389075","title":"中国生物科技服务(08037)：湖北惟宥拟向鹏博(海南)注资最多5000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389075","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514389075?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:25","pubTimestamp":1740669904,"startTime":"0","endTime":"0","summary":"在注资额人民币5000万元中，人民币1666.67万元将入账作为鹏博(海南)的注册资本，其余人民币3333.33万元将入账至股份溢价账。本公司认为，注资协议及其项下拟进行的交易将为硼中子俘获治疗中心的发展提供更多资金。此外，注资所得款项最多人民币5000万元预期将用于清偿鹏博(海南)现有贷款;及硼中子俘获治疗中心的建设、开发及营运。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1511","BK1219","08037"],"gpt_icon":0},{"id":"2514614022","title":"中国生物科技服务与华大基因签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2514614022","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514614022?lang=zh_cn&edition=full","pubTime":"2025-02-26 09:22","pubTimestamp":1740532955,"startTime":"0","endTime":"0","summary":"2月26日，中国生物科技服务（08037）发布公告，宣布与深圳华大基因科技有限公司签署了战略合作框架协议，并与鹏博（海南）硼中子医疗科技有限公司签署了投资意向书。框架协议的主要内容包括双方将在BNCT治疗合作、CAR-T治疗研究和应用、治疗后监测和疗效评估、肿瘤精准诊断与筛查等领域进行合作，目标是推动相关技术在中国的临床应用与学术推广。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502263329802187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1219","08037","BK1511"],"gpt_icon":0},{"id":"2514902999","title":"中国生物科技服务与深圳华大基因科技订立战略合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2514902999","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514902999?lang=zh_cn&edition=full","pubTime":"2025-02-26 08:16","pubTimestamp":1740528960,"startTime":"0","endTime":"0","summary":"　　中国生物科技服务发布公告，于2025年2月25日， 公司与深圳华大基因科技有限公司订立战略合作框架协议：双方联合开展基于BNCT治疗的临床研究，推动BNCT技术在中国境内的临床应用和学术推广。　　华大与公司在肿瘤精准诊断、治疗及技术研发领域具有互补性，并愿意基于平等互利，合作共赢，共同发展的原则开展长期战略合作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-26/doc-inemuerp0636657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0221","08037","BK0042","BK0197","300676","BK0196","BK0046","BK1511","BK1219"],"gpt_icon":0},{"id":"2514097965","title":"【中国生物科技服务(08037.HK)与深圳华大基因科技订立战略合作框架协议】中国生物科技服务(08037.HK)发布公告，于2025年2月25日， 公司与深圳华大基因科技有限公司(深圳华大科技)订立战略合作框架协议：(1)双方联合开展基于BNCT治疗的临床研究，推动BNCT技术在中国境内的临床应用和学术推广。(2)双方联合开展基于新型靶向CD20 CAR-T治疗方法的学术研究，共同探索临床应用和推广转化的商业路径，推动该新型治疗方法助益更广泛适宜患者人群。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097965","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514097965?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:22","pubTimestamp":1740493354,"startTime":"0","endTime":"0","summary":"中国生物科技服务(08037.HK)发布公告，于2025年2月25日， 公司与深圳华大基因科技有限公司(深圳华大科技)订立战略合作框架协议：(1)双方联合开展基于BNCT治疗的临床研究，推动BNCT技术在中国境内的临床应用和学术推广。(2)双方联合开展基于新型靶向CD20 CAR-T治疗方法的学术研究，共同探索临床应用和推广转化的商业路径，推动该新型治疗方法助益更广泛适宜患者人群。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25222248383570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0046","BK4230","08037","BK1219","BK0197","BK0196","BK0221","BK1511","CAR","BK0042","BK4022","300676"],"gpt_icon":0},{"id":"2514097882","title":"中国生物科技服务(08037)与深圳华大基因科技订立战略合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097882","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514097882?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:17","pubTimestamp":1740493070,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物科技服务 发布公告，于2025年2月25日， 公司与深圳华大基因科技有限公司订立战略合作框架协议：双方联合开展基于BNCT治疗的临床研究，推动BNCT技术在中国境内的临床应用和学术推广。深圳华大科技作为优先合作伙伴，为公司提供肿瘤治疗后检测产品和解决方案，用于患者治疗后的效果监测评估及长期随访。海南博鳌BNCT硼中子治疗中心计划于2025年第四季度开业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","BK1511","08037","BK0197","BK0196","BK0221","300676","BK0042","BK0046"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ruikang.com.hk","stockEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.1625},{"period":"3month","weight":-0.0792},{"period":"6month","weight":0.1481},{"period":"1year","weight":1.0667},{"period":"ytd","weight":0.8235}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国生物科技服务控股有限公司（原名：锐康药业集团投资有限公司）是一家主要从事提供医学检测服务的投资控股公司。该公司通过六个分部运营业务。医学及保健相关服务分部主要提供医学实验室检测服务及健康检查服务。保险经纪分部主要提供保险经纪服务。免疫治疗分部主要提供肿瘤免疫细胞治疗、免疫细胞存储及健康管理服务。医药产品分部主要制造、研发、销售及分销保健相关及医药产品。证券分部主要从事买卖证券业务。其他分部主要从事放债业务及提供物流服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.190476,"avgChangeRate":-0.025851},{"month":2,"riseRate":0.47619,"avgChangeRate":0.104887},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.063234},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.007021},{"month":5,"riseRate":0.714286,"avgChangeRate":0.103641},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.012662},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.031808},{"month":8,"riseRate":0.318182,"avgChangeRate":0.00375},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.041523},{"month":10,"riseRate":0.318182,"avgChangeRate":0.014648},{"month":11,"riseRate":0.454545,"avgChangeRate":0.045242},{"month":12,"riseRate":0.545455,"avgChangeRate":-0.002352}],"exchange":"SEHK","name":"中国生物科技服务","nameEN":"CH BIOTECH SER"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国生物科技服务(08037)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国生物科技服务(08037)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国生物科技服务,08037,中国生物科技服务股票,中国生物科技服务股票老虎,中国生物科技服务股票老虎国际,中国生物科技服务行情,中国生物科技服务股票行情,中国生物科技服务股价,中国生物科技服务股市,中国生物科技服务股票价格,中国生物科技服务股票交易,中国生物科技服务股票购买,中国生物科技服务股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国生物科技服务(08037)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国生物科技服务(08037)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}